Share This
table started by
bioventurist for the BioVenturist Base
There is no user-contributed description yet.
Add More Topics
Save this view to a base, or just for yourself.
441 BV: Medical Condition topics matching:
Filter this Collection
+
|
|
|
||||
|---|---|---|---|---|---|
| x name | x image | x Therapeutics | x article | ||
| x Therapeutics | x Phase of development | x Notes | |||
| x Anemia |
|
Darbepoetin alfa | On the market |
Anemia (pronounced /əˈniːmiə/, also spelled anaemia or anæmia; from Ancient Greek ἀναιμία anaimia, meaning "lack of blood") is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However...
|
|
| Mircera | Awaiting Approval | ||||
| Epoetin alfa | On the market | ||||
| Denosumab | Phase III Clinical Trial | ||||
| AKB-6548 | Pre-clinical development | ||||
| x Cardiovascular disease |
|
Cinacalcet | Phase III Clinical Trial |
Cardiovascular disease or cardiovascular diseases is the class of diseases that involve the heart or blood vessels (arteries and veins). While the term technically refers to any disease that affects the cardiovascular system (as used in MeSH), it...
|
|
| TheraPlas | Pre-clinical development | ||||
| MK-0448 | Phase I Clinical Trial | ||||
| MK-1809 | Phase I Clinical Trial | ||||
| MK-8141 | Phase II Clinical Trial | ||||
| more ▼ | |||||
| x Cancer |
|
Depocyt | On the market |
Cancer (medical term: malignant neoplasm) is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread...
|
|
| PD-332,991 | Phase I Clinical Trial | ||||
| CP-870,893 | Phase I Clinical Trial | ||||
| PF-2,341,066 | Phase I Clinical Trial | ||||
| PF-562,271 | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Graduate school |
A graduate school (or grad school) is a school that awards advanced academic degrees with the general requirement that students must have earned a previous undergraduate (bachelor's) degree. Many universities award graduate degrees; a graduate...
|
||||
| x Colorectal cancer |
|
Panitumumab | On the market |
Colorectal cancer, also called colon cancer or large bowel cancer, includes cancerous growths in the colon, rectum and appendix. With 655,000 deaths worldwide per year, it is the third most common form of cancer and the third leading cause of cancer...
|
|
| Fluorouracil | On the market | Indicated for first or second line treatment for metastatic carcinoma of the colon or rectum | |||
| Bevacizumab | On the market | ||||
| Cetuximab | Phase III Clinical Trial | ||||
| Edrecolomab | Awaiting Approval | ||||
| more ▼ | |||||
| x Neutropenia |
|
Filgrastim | On the market |
Neutropenia (adjective neutropenic), from Latin prefix neutro- and Greek suffix -πενία (deficiency) is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood....
|
|
| x Myocardial infarction |
|
TNKase | On the market |
Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack, is the interruption of blood supply to part of the heart, causing some heart cells to die. This is most commonly due to occlusion (blockage) of a...
|
|
| Aspirin Cardio | On the market | ||||
| x Non-small cell lung cancer staging |
Non-small cell lung carcinoma (NSCLC) is any type of lung cancer other than small cell carcinoma (SCLC). As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma.
The most common types of NSCLC are squamous...
|
||||
| x Breast cancer |
|
Myocet | On the market |
Breast cancer is a cancer that starts in the breast, usually in the inner lining of the milk ducts or lobules. There are different types of breast cancer, with different stages (spread), aggressiveness, and genetic makeup. With best treatment, 10...
|
|
| Trastuzumab | On the market | ||||
| Paclitaxel | On the market | Indicated for patients who have not received chemotherapy for metastatic HER2-negative breast cancer. | |||
| Bevacizumab | Awaiting Approval | ||||
| Pre-clinical development | |||||
| more ▼ | |||||
| x Non-Hodgkin lymphoma |
|
Rituximab | On the market |
Distinct from Hodgkin lymphoma both morphologically and biologically, Non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy...
|
|
| Ibritumomab tiuxetan | On the market | ||||
| SGN-40 | Phase III Clinical Trial | ||||
| GEN - 3rd Generation Anti-CD20 | Phase I Clinical Trial | ||||
| CMC544 | Phase III Clinical Trial | ||||
| more ▼ | |||||
| x Aesthetic Medicine | |||||
| x Central Nervous System Diseases |
Central nervous system diseases is a broad classification for medical conditions relating the the central nervous system.
|
||||
| x Acne vulgaris |
|
Yasmin | On the market |
Acne vulgaris (commonly called acne) is a common skin condition, caused by changes in pilosebaceous units, skin structures consisting of a hair follicle and its associated sebaceous gland, via androgen stimulation. It is characterized by...
|
|
| x Fungal Infections | Abelcet | On the market | |||
| Amphotec | On the market | ||||
| Ambisome | On the market | ||||
| Doxil/Caefyx | On the market | ||||
| Fluconazole | On the market | ||||
| more ▼ | |||||
| x Kaposi's sarcoma |
|
DaunoXome | On the market |
A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it...
|
|
| x Age-Related Macular Degeneration |
|
Visudyne | On the market |
Age related macular degeneration is a degenerative condition of the macula as a result of hardening of the arteries of the retina.
|
|
| PF-4,523,655 | Phase II Clinical Trial | ||||
| RTP801i-14 | Phase II Clinical Trial | ||||
| x Hepatitis A |
|
Epaxal Berna | On the market |
Hepatitis A (formerly known as infectious hepatitis) is an acute infectious disease of the liver caused by the hepatitis A virus (HAV), which is most commonly transmitted by the fecal-oral route via contaminated food or drinking water. Every year,...
|
|
| x Influenza |
|
Inflexal V Berna | On the market |
Influenza, commonly referred to as the flu, is an infectious disease caused by RNA viruses of the family Orthomyxoviridae (the influenza viruses), that affects birds and mammals. The name influenza is Italian and means "influence" (Latin: influentia...
|
|
| PF-4,522,625 | Phase I Clinical Trial | ||||
| ANX-201 | Pre-clinical development | ||||
| x Menopause | Estrasorb | On the market |
Menopause is the permanent cessation of reproductive fertility occurring some time before the end of the natural lifespan. The term was originally coined to describe this reproductive change in human females, where the end of fertility is...
|
||
| x Immunodeficiency | Adagen | On the market |
Immunodeficiency (or immune deficiency) is a state in which the immune system's ability to fight infectious disease is compromised or entirely absent. Most cases of immunodeficiency are acquired ("secondary") but some people are born with defects in...
|
||
| x Febrile neutropenia | Pegfilgrastim | On the market |
Febrile neutropenia is the development of fever, often with other signs of infection, in a patient with neutropenia, an abnormally low number of neutrophil granulocytes (a type of white blood cell) in the blood. The term neutropenic sepsis is also...
|
||
| x Leukemia |
|
Oncaspar | On the market |
Leukemia (British English: leukaemia) (Greek leukos λευκός, "white"; aima αίμα, "blood") is a cancer of the blood or bone marrow and is characterized by an abnormal proliferation (production by multiplication) of blood cells, usually white blood...
|
|
| x Hepatitis C |
|
PEGASYS | On the market |
Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but once established, chronic infection can progress to scarring of the liver (fibrosis), and advanced scarring ...
|
|
| PEG-Intron | On the market | ||||
| PF-868,554 | Phase II Clinical Trial | ||||
| SPC3649 | Phase I Clinical Trial | ||||
| x Rheumatoid arthritis |
|
Rituximab | On the market |
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks the joints producing an inflammatory synovitis that often progresses to destruction of the articular cartilage...
|
|
| Adalimumab | On the market | ||||
| Denosumab | Phase II Clinical Trial | ||||
| CP-690,550 | Phase II Clinical Trial | ||||
| PH-797,804 | Phase II Clinical Trial | ||||
| more ▼ | |||||
| x Human respiratory syncytial virus |
|
Palivizumab | On the market |
Human respiratory syncytial virus (RSV) causes respiratory tract infections. It is the major cause of lower respiratory tract infection and hospital visits during infancy and childhood. There is no vaccine, and the only treatment is oxygen.
In...
|
|
| ALN-RSV01 | Phase II Clinical Trial | ||||
| x Chronic Childhood Arthritis |
|
Adalimumab | On the market |
Juvenile idiopathic arthritis (JIA) is the most common form of persistent arthritis in children. (Juvenile in this context refers to an onset before age 16, idiopathic refers to a condition with no defined cause, and arthritis is the inflammation of...
|
|
| x Psoriasis |
|
Adalimumab | On the market |
Psoriasis (pronounced /səˈraɪəsɪs/) is a chronic, non-contagious autoimmune disease that affects the skin and joints. It commonly causes red, scaly patches to appear on the skin. The scaly patches caused by psoriasis, called psoriatic plaques, are...
|
|
| Efalizumab | On the market | ||||
| CP-690,550 | Phase I Clinical Trial | ||||
| AMG 714 | On the market | ||||
| Hectorol | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Psoriatic arthritis |
|
Adalimumab | On the market |
Psoriatic arthritis (also arthritis psoriatica, arthropathic psoriasis or psoriatic arthropathy) is a type of inflammatory arthritis that, according to the National Psoriasis Foundation, affects around 10-30% of people suffering from the chronic...
|
|
| Etanercept | On the market | ||||
| Apremilast | Phase II Clinical Trial | ||||
| Infliximab | On the market | ||||
| x Ankylosing spondylitis |
|
Adalimumab | On the market |
Ankylosing spondylitis (AS, from Greek ankylos, bent; spondylos, vertebrae), previously known as Bechterew's disease, Bechterew syndrome, and Marie Strümpell disease, a form of Spondyloarthritis, is a chronic, inflammatory arthritis and autoimmune...
|
|
| Etanercept | On the market | ||||
| Infliximab | On the market | ||||
| x Crohn's disease |
|
Adalimumab | On the market |
Crohn's disease (also known as granulomatous colitis and regional enteritis) is an inflammatory disease of the intestines that may affect any part of the gastrointestinal tract from anus to mouth, causing a wide variety of symptoms. It primarily...
|
|
| Certolizumab pegol | Awaiting Approval | ||||
| Infliximab | |||||
| Laquinimod | Phase II Clinical Trial | ||||
| x Ischemia | Abciximab | On the market |
In medicine, ischemia (Greek ισχαιμία, isch- is restriction, hema or haema is blood) is a restriction in blood supply, generally due to factors in the blood vessels, with resultant damage or dysfunction of tissue. It may also be spelled ischaemia or...
|
||
| x Asthma |
|
Omalizumab | On the market |
Asthma is characterized by a predisposition to chronic inflammation of the lungs in which the airways (bronchi) are reversibly narrowed. Asthma affects 7% of the population of the United States, and 300 million worldwide. During asthma attacks ...
|
|
| PF-610,355 | Phase II Clinical Trial | ||||
| PF-3,893,787 | Phase I Clinical Trial | ||||
| PF-4,191,834 | Phase I Clinical Trial | ||||
| PF-3,526,299 | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Chronic lymphocytic leukemia |
|
Alemtuzumab | On the market |
B-cell chronic lymphocytic leukemia (B-CLL), also known as chronic lymphoid leukemia (CLL), is the most common type of leukemia. Leukemias are abnormal and malignant neoplastic proliferations ("cancers") of the white blood cells (leukocytes). CLL...
|
|
| GEN - 3rd Generation Anti-CD20 | Phase I Clinical Trial | ||||
| ABT-263 | Phase I Clinical Trial | ||||
| Rituximab | Phase III Clinical Trial | ||||
| Lumiliximab | Phase III Clinical Trial | ||||
| more ▼ | |||||
| x Transplant rejection | Basiliximab | On the market |
Transplant rejection occurs when a transplanted organ or tissue is not accepted by the body of the transplant recipient. This is explained by the concept that the immune system of the recipient attacks the transplanted organ or tissue. This is...
|
||
| Muromonab | On the market | ||||
| Daclizumab | On the market | ||||
| Rapamune | On the market | ||||
| CP-690,550 | Phase II Clinical Trial | ||||
| x Acute myeloid leukemia |
|
Gemtuzumab ozogamicin | On the market |
Acute myeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the...
|
|
| Lintuzumab | Phase I Clinical Trial | ||||
| CPX-351 | Phase I Clinical Trial | ||||
| Clofarabine | Phase III Clinical Trial | ||||
| Trisenox | On the market | ||||
| more ▼ | |||||
| x Follicular lymphoma | Tositumomab | On the market |
Follicular lymphoma is the second most common of the indolent non-Hodgkin's lymphomas. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. It is positive for CD10,...
|
||
| AEG35156 | Phase I/II Clinical Trial | ||||
| x Multiple myeloma |
|
SGN-40 | Phase III Clinical Trial |
Multiple myeloma (from myelo-, bone marrow), also known as MM, myeloma, plasma cell myeloma, or as Kahler's disease (after Otto Kahler) is a cancer of the white blood cells known as plasma cells. A type of B cell, plasma cells are a crucial part of...
|
|
| Denosumab | Phase II Clinical Trial | ||||
| GEN - Anti-CD40 | Phase I Clinical Trial | ||||
| Bevacizumab | Phase II Clinical Trial | ||||
| CEP-18770 | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Myelodysplastic syndrome | Lintuzumab | Phase I Clinical Trial |
The myelodysplastic syndromes (MDS, formerly known as "preleukemia") are a diverse collection of hematological conditions united by ineffective production (or dysplasia) of myeloid blood cells and risk of transformation to acute myelogenous leukemia...
|
||
| Romiplostim | Phase II Clinical Trial | ||||
| Thymoglobulin | Phase II Clinical Trial | ||||
| REVLIMID | On the market | ||||
| CC-11006 | Phase II Clinical Trial | ||||
| more ▼ | |||||
| x Hodgkin's lymphoma |
|
SGN-35 | Phase I Clinical Trial |
Hodgkin's lymphoma, previously known as Hodgkin's disease, is a type of lymphoma, which is a type of cancer originating from white blood cells called lymphocytes. It was named after Thomas Hodgkin, who first described abnormalities in the lymph...
|
|
| MGCD0103 | Phase II Clinical Trial | ||||
| x Autoimmune Disease | SGN-70 | Pre-clinical development |
This is a group of diseases in which the body's own defenses (immune system) attack its own tissues. See Autoimmunity, specific diseases or Assassination In Ways Which Appear Natural for more.
|
||
| ACT_S1P1_Agonist | Phase I Clinical Trial | ||||
| x Renal Cancer |
|
SGN-75 | Pre-clinical development |
Kidney cancer is usually defined as any cancer that is determined to have arisen from the kidney. It usually does not include metastatic cancer of the kidney, i.e. cancer that arose outside of the kidney and has spread to it.
The two most common...
|
|
| OGX-427 | Phase I Clinical Trial | ||||
| OGX-427 | Phase I Clinical Trial | ||||
| x Acromegaly |
|
Somavert | On the market |
Acromegaly (pronounced /ækroʊˈmeɪgʌliː/) (from Greek akros "extreme" or "extremities" and megalos "large" - extremities enlargement) is a syndrome that results when the pituitary gland produces excess growth hormone (hGH) after epiphyseal plate...
|
|
| x Chronic renal failure |
|
Renagel | On the market |
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss of renal function over a period of months or years. The symptoms of worsening kidney function are unspecific, and might include feeling generally unwell and...
|
|
| Denosumab | Phase III Clinical Trial | ||||
| x Nausea and Vomiting Caused by Chemotherapy | Emend | On the market | |||
| x Head and neck cancer |
|
Panitumumab | Phase III Clinical Trial |
The term head and neck cancer refers to a group of biologically similar cancers originating from the upper aerodigestive tract, including the lip, oral cavity (mouth), nasal cavity, paranasal sinuses, pharynx, and larynx. Most head and neck cancers...
|
|
| TheraPlas | Pre-clinical development | ||||
| Abraxane | Phase II Clinical Trial | ||||
| ANX-514 | |||||
| x Immune thrombocytopenic purpura | Romiplostim | On the market | |||
| Romiplostim | Phase III Clinical Trial | ||||
| x Bone Metastases | Denosumab | Phase III Clinical Trial | |||
| x Bone Damage from Cancer | Denosumab | Phase III Clinical Trial | |||
| x Postmenopausal osteoporosis | Denosumab | Phase III Clinical Trial |
Postmenopausal osteoporosis is a form of osteoporosis that commonly occurs during the decades after menopause. It is a pathological condition of the human skeleton that is characterized by the following features :
Osteoporosis is assessed,...
|
||
| Alendronate | On the market | ||||
| x Chronic Fibrotic Disease | |||||
| x Hypertension |
|
Doxazosin | On the market |
Hypertension is a chronic medical condition in which the blood pressure is elevated. It is also referred to as high blood pressure or shortened to HT, HTN or HPN. The word "hypertension", by itself, normally refers to systemic, arterial hypertension...
|
|
| Caduet | On the market | ||||
| Amlodipine | On the market | ||||
| Losartan | On the market | ||||
| Enalapril | On the market | ||||
| more ▼ | |||||
| x Vitamin D Deficiency | |||||
| x Pain management |
|
Pain management (also called pain medicine) is the medical discipline concerned with the relief of pain.
Acute pain, such pain resulting from trauma, often has a reversible cause and may require only transient measures and correction of the...
|
|||
| x Pain |
|
PH-797,804 | Phase II Clinical Trial |
Physical Pain is the unpleasant feeling common to a headache and a stubbed toe. It typically consists of negative affect and aversion, and has location, duration, intensity and a distinctive quality (e.g., burning, stabbing). Pain is often...
|
|
| PF-4,383,119 | Phase II Clinical Trial | ||||
| PF-4,856,880 | Phase II Clinical Trial | ||||
| PF-4,856,881 | Phase I Clinical Trial | ||||
| PF-3,557,156 | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Hormone replacement therapy |
Hormone replacement therapy (HRT) or in Britain, Hormone therapy (HT), is a system of medical treatment for surgically menopausal, perimenopausal and to a lesser extent postmenopausal women. It is based on the idea that the treatment may prevent...
|
||||
| x Alzheimer's disease |
|
Rember | Phase II Clinical Trial |
Alzheimer's disease (AD), also called Alzheimer disease, Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer's, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German...
|
|
| PF-4,494,700 | Phase II Clinical Trial | ||||
| PF-3,084,014 | Phase I Clinical Trial | ||||
| Donepezil | On the market | ||||
| V950 | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Parkinson's disease |
|
MK-0657 | Phase I Clinical Trial |
Parkinson's disease (also known as Parkinson disease or PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Parkinson's disease belongs to a group of conditions...
|
|
| Rotigotine | On the market | ||||
| BIIB014 | Phase II Clinical Trial | ||||
| x Schizophrenia |
|
PF-2,545,920 | Phase II Clinical Trial |
Schizophrenia (pronounced /ˌskɪtsɵˈfrɛniə/ or /ˌskɪtsɵˈfriːniə/), from the Greek roots skhizein (σχίζειν, "to split") and phrēn, phren- (φρήν, φρεν-; "mind") is a psychiatric diagnosis that describes a mental disorder characterized by abnormalities...
|
|
| PF-217,830 | Phase II Clinical Trial | ||||
| PF-2,400,013 | Phase I Clinical Trial | ||||
| PF-3,463,275 | Phase I Clinical Trial | ||||
| PF-3,654,746 | Phase I Clinical Trial | ||||
| more ▼ | |||||
| x Epilepsy |
|
Pregabalin | Phase III Clinical Trial |
Epilepsy (from the Ancient Greek ἐπιληψία epilēpsía) is a common chronic neurological disorder characterized by recurrent unprovoked seizures. These seizures are transient signs and/or symptoms of abnormal, excessive or synchronous neuronal activity...
|
|
| Gabapentin | On the market | ||||
| Pregabalin | On the market | ||||
| Levetiracetam | On the market | ||||
| Lacosamide | Awaiting Approval | ||||
| more ▼ | |||||
| x Clinical depression |
|
Sertraline | On the market |
Major depressive disorder (also known as clinical depression, major depression, unipolar depression, or unipolar disorder) is a mental disorder characterized by an all-encompassing low mood accompanied by low self-esteem, and loss of interest or...
|
|
